IP Library Granted Patent US 8,883,015
Granted Patent B2
US 8,883,015 · App. 12/866,717 · Granted Nov 11, 2014

Patch production

Inventors: Mark Anthony Fernance Kendall (Chelmer, AU); Derek William Kenneth Jenkins (Wantage, GB)
Assignee: The University of Queensland
B81C1/00111A61M2037/0046A61M37/0015B81B2201/055A61M2037/0023A61M2037/0053
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,015
App. No.
12/866,717
Granted
Nov 11, 2014
Kind
B2
Abstract

A method of producing projections on a patch including providing a mask on a substrate and etching the substrate using an etchant and a passivant to thereby control the etching process and form the projections, wherein the passivant does not include oxygen.

Claims (66)

1. A method of producing projections on a patch, the method including:

a) providing a mask on a substrate; and,

b) etching the substrate using a mixture of an etchant and a passivant to thereby control the etching process and form the projections, wherein the etching process is controlled by varying a ratio of the etchant to the passivant in the mixture, wherein the ratio is in the range of 0.25 to 0.60, and wherein the passivant does not include oxygen.

2. A method according to claim 1 , wherein the mask includes an organic photo-resist.

3. A method according to claim 1 , wherein the passivant is a gas including:

a) at least one of:

i) carbon; and,

ii) silicon; and,

b) at least one of:

i) chlorine; and,

ii) fluorine.

4. A method according to claim 1 , wherein the passivant is at least one of:

a) a per-fluoride hydrocarbon;

b) a fluorinated olefine;

c) Octafluorocyclobutane;

d) Perfluoroisobutene; and,

e) C 4 F 8 .

5. A method according to claim 1 , wherein the etchant is a gas or plasma.

6. A method according to claim 1 , wherein the etchant is sulfur hexa-fluoride.

7. A method according to claim 1 , wherein the method includes, controlling the etching process by varying etching parameters including at least one of:

a) a gas flow for at least one of the etchant and the passivant; and,

b) a pressure for at least one of the etchant and the passivant.

8. A method according to claim 7 , wherein the pressure of at least one of the etchant and the passivant is in the range of 0 to 26.7 Pa.

9. A method according to claim 7 , wherein the pressure of at least one of the etchant and the passivant is in the range of 0.67 to 8.0 Pa.

10. A method according to claim 7 , wherein the etchant is supplied at a flow rate in the range of 0 to 200 sccm.

11. A method according to claim 1 , wherein the passivant is supplied at a flow rate in the range of 0 to 200 sccm.

12. A method according to claim 1 , wherein the method includes:

a) applying a mask material to the substrate; and,

b) selectively exposing the mask material to radiation to thereby form the mask.

13. A method according to claim 12 , wherein the mask material is at least one of:

a) an organic photo-resist;

b) a polymer mask; and,

c) a crosslinked epoxy resin.

14. A method according to claim 12 , wherein the mask material is Su-8.

15. A method according to claim 1 , wherein the method includes, performing post-etch processing.

16. A method according to claim 15 , wherein the method includes, chemically sharpening the projections.

17. A method according to claim 15 , wherein the method includes, sharpening the projections by:

a) forming a silicon dioxide layer on the projections; and,

b) removing the silicon dioxide layer.

18. A method according to claim 17 , wherein the method includes forming a silicon dioxide layer on the projections by heating the projections in an oxygen rich environment.

19. A method according to claim 18 , wherein the method includes heating the projections to a temperature of greater than 1000° C.

20. A method according to claim 17 , wherein the method includes removing the silicon dioxide using 10% HF.

21. A method according to claim 1 , wherein the method includes, applying a coating to the projections.

22. A method according to claim 21 , wherein the coating is a metallic coating.

23. A method according to claim 21 , wherein the method includes using sputter deposition to deposit:

a) an adhesion layer; and,

b) a metallic layer on the adhesion layer.

24. A method according to claim 23 , wherein the adhesion layer includes chromium.

25. A method according to claim 22 , wherein the metallic coating includes gold.

26. A method according to claim 1 , wherein the method further includes coating the projections with a material.

27. A method according to claim 26 , wherein the material is a therapeutic agent.

28. A method according to claim 1 , wherein the patch has a surface area of approximately 0.4 cm 2 .

29. A method according to claim 1 , wherein the projections have a density of between 1,000-30,000 projections/cm 2 .

30. A method according to claim 1 , wherein the projections have a density of 20,000 projections/cm 2 .

31. A method according to claim 1 , wherein the projections have a length of between 10 to 200 μm.

32. A method according to claim 1 , wherein the projections have a length of 90 μm.

33. A method according to claim 1 , wherein the projections have a radius of curvature of greater than 1 μm.

34. A method according to claim 1 , wherein the projections have a radius of curvature greater than 5 μm.

35. A method according to claim 1 , wherein the projections include a support section and a targeting section.

36. A method according to claim 35 , wherein the targeting section has a diameter of less than 1 μm.

37. A method according to claim 35 , wherein a length for the targeting section is less than 2.0 μm.

38. A method according to claim 35 , wherein a length for the support section is at least one of:

a) for epidermal delivery <200 μm;

b) for dermal cell delivery <1000 μm;

c) for delivery to basal cells in the epithelium of the mucosa 600-800 μm; and,

d) for lung delivery of the order of 100 μm an in this case.

Assignments (6)
CHANGE OF ADDRESS Recorded Feb 20, 2018
From: VAXXAS PTY LIMITED
To: VAXXAS PTY LIMITED
Reel/Frame 045640/0798 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2017
From: THE UNIVERSITY OF QUEENSLAND
To: UNIQUEST PTY LIMITED
Reel/Frame 043368/0707 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2017
From: UNIQUEST PTY LIMITED
To: VAXXAS PTY LIMITED
Reel/Frame 043456/0271 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2012
From: KENDALL, MARK ANTHONY FERNANCE
To: THE UNIVERSITY OF QUEENSLAND
Reel/Frame 028116/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2012
From: JENKINS, DEREK WILLIAM KENNETH
To: SCIENCE AND TECHNOLOGY FACILITIES COUNCIL
Reel/Frame 028116/0155 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2012
From: SCIENCE AND TECHNOLOGY FACILITIES COUNCIL
To: THE UNIVERSITY OF QUEENSLAND
Reel/Frame 028116/0168 →
Continuity (2)
Provisional Application 61063932 · Feb 7, 2008
Related Publication 20110223542A1 · Sep 15, 2011